Artemida Pharma Ltd, incorporating Artemida Pharma Europe Ltd, is a well-established drug development consultancy with a specialism in oncology. It offers optimised strategic drug development from product concept to clinical proof of concept for biotech and pharma clients. Over the past 20 years the team has been involved in the provision of development planning for oncology indications in both solid and haematological tumours. Its involvement commences with mode of action or potential target elucidation and indication seeking to optimise the development pathway and assist companies in moving to proof of concept. Identification of the most appropriate development and regulatory path includes support with regulatory interactions and document authoring, along with technical, scientific and medical support and project management. Artemida also offers flexible services covering the implementation of clinical programmes, ranging from full-service development to stand- alone services that are tailored to project-specific needs. The team work with their own selected team or suppliers selected by the client (guiding and representing the client where appropriate), or even with client resources, allowing them to complement their resources where necessary. Artemida Pharma has supported companies Artemida Pharma Ltd
ARTEMIDA PHARMA LTD Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2FX ARTEMIDA PHARMA EUROPE LTD Fitzwilliam Hall, Fitzwilliam Place, Dublin 2, Ireland
Tel/fax: +44 (0)800 689 4391 info@artemidapharma.com www.artemidapharma.com
Receiving the Queen’s Award from the Lord Lieutenant of Hertfordshire
ranging from a large multinational peri-approval programme to micro-start-ups from academia. More recently it is working with several companies in the immune-oncology field in solid tumours and photodynamic therapies as well as with targeted therapies in haematological indications. Through its work with scientific advisory boards it has access to many key opinion leaders who help validate the development strategy. Its regulatory activities have involved successful interactions with European, US, South American and Australian regulators and ethics committees to gain IND/CTAs/ MAAs and orphan designations.
Artemida Pharma Managing Partners meet HRH Prince Charles at Buckingham Palace on 28 June 2018
Chipside
One of the nation’s most popular brands, Chipside won its first Queen’s Award for Enterprise (Innovation) in 2019, in recognition of its innovative digital permit platform. The company has continued to grow strongly since the award and has built a public user base of some six million people. Today, 170 local and regional government authorities use the platform 24/7 to help their residents, visitors and businesses with their transport and parking regulations. Chipside recently opened a new regional office in Wales to help support the demand for its services. The award reflects the effort,
international recognition and helped us to secure partners across the globe,” says Paul Moorby OBE, CEO of Chipside. “Closer to home, it is a source of pride to be able to look out from our desks and see the flag flying, reminding us of why we work so hard to be the very best that we can be.” The UK is a world leader in open data. Richy Clements, Director of
Paul Moorby OBE
ethos and commitment to achieving consistently high standards in all areas of operation, from software innovation to end user technical support. Celebrating its 20th year during 2022, the team at Chipside have a clear innovation roadmap towards the next generation of products and services. One of those projects brings together InnovateUK, the University of Bath and Chipside to look at how Artificial Intelligence can improve outcomes for drivers as towns and cities implement their net zero policies. “The Queen’s Award is hugely respected across the world. Winning the award has brought us
Innovation Lab, is clear of the role Chipside will play over the next few years: “The public rightly demands access to their government services at the time of their choosing, on the platform they wish, with outcomes taking seconds, not weeks. We have exciting partnerships in place to meet that challenge.” CHIPSIDE Unit 7, Callow Hill, Brinkworth, Chippenham SN15 5FD Tel: +44 (0)345 470 9009 • Fax: +44 (0)345 470 9010 www.chipside.com
www. queensawardsmagazine .com
138
Made with FlippingBook Converter PDF to HTML5